The Top Line cover image

Biopharma's rebound keeping pace so far

The Top Line

00:00

KPMG's 2026 investment outlook

Fraiser asks Kristin Pothier for top-line highlights from KPMG's new healthcare and life sciences investment outlook.

Play episode from 01:43
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app